Articles

Results 1 to 5 of 19
Most popular |Most recent


Federal and State Cannabis Rules Are Moving in Different Directions

USA - June 3 2021 Federal and state cannabis regulation and enforcement appear to be moving in different directions. While the Food and Drug Administration (“FDA”) has…

Delia A. Deschaine, Nathaniel M. Glasser.

Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking

USA - September 3 2020 This Diagnosing Health Care Episode dives into the status of the Food and Drug Administration’s (“FDA’s”) plan for regulating cannabis and…

Delia A. Deschaine.

FDA Issues Draft Guidance on Cannabis Clinical Research and Sends CBD Enforcement Discretion Guidance to OMB for Review

USA - July 28 2020 FDA took two important steps last week to clarify the regulatory landscape for cannabis products, including CBD products. First, FDA issued a draft…

Delia A. Deschaine, James A. Boiani.

Federal Courts Say They Will Decide Cases Against CBD Product Manufacturers When the Smoke Clears

USA - July 13 2020 The cannabidiol (“CBD”) consumer product marketplace is booming. And, while FDA has maintained its position that CBD, even hemp-derived CBD, may not…

Delia A. Deschaine.

Telehealth Flexibility: Key Regulatory Changes Impacting Providers During and Beyond the Coronavirus Pandemic

USA - July 9 2020 This Diagnosing Health Care Episode focuses on the growing opportunity for providers to integrate telehealth into their practice through a compliant…

Amy F. Lerman, Kevin J. Ryan.